Amylyx Pharmaceuticals Secures $5,000,000 Series A Round

  • Feed Type
  • Date
    8/24/2016
  • Company Name
    Amylyx Pharmaceuticals
  • Mailing Address
    210 Broadway Cambridge, MA 02139 USA
  • Company Description
    Amylyx is an IND-enabling stage biopharmaceutical company dedicated to providing innovative, disease-modifying solutions for neurodegenerative diseases. We have a highly creative and motivated team focused on streamlined clinical development and drug discovery.
  • Website
    http://www.amylyx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Our investment in Amylyx is aligned with the Fund’s goals of driving medical advancement for this terrible disease.
  • M&A Terms
  • Venture Investor
    Morningside Group
  • Venture Investor
    Investor

Trending on Xconomy